Your browser doesn't support javascript.
loading
Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis.
Manka, Laurie A; Guntur, Vamsi P; Denson, Joshua L; Dunn, Ryan M; Dollin, Yeshai T; Strand, Matthew J; Wechsler, Michael E.
Affiliation
  • Manka LA; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; The Cohen Family Asthma Institute, National Jewish Health, Denver, Colorado.
  • Guntur VP; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; The Cohen Family Asthma Institute, National Jewish Health, Denver, Colorado.
  • Denson JL; Division of Pulmonary Diseases, Critical Care & Environmental Medicine, Tulane University, New Orleans, Louisiana.
  • Dunn RM; OSF HealthCare, Division of Lung and Pulmonology, Peoria, Illinois.
  • Dollin YT; University of Colorado School of Medicine, Aurora, Colorado.
  • Strand MJ; Division of Biostatistics, National Jewish Health, Denver, Colorado.
  • Wechsler ME; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; The Cohen Family Asthma Institute, National Jewish Health, Denver, Colorado. Electronic address: wechslerm@njhealth.org.
Ann Allergy Asthma Immunol ; 126(6): 696-701.e1, 2021 06.
Article in En | MEDLINE | ID: mdl-33548468

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-5 / Anti-Asthmatic Agents / Eosinophilia / Antibodies, Monoclonal, Humanized Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Allergy Asthma Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-5 / Anti-Asthmatic Agents / Eosinophilia / Antibodies, Monoclonal, Humanized Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Allergy Asthma Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Country of publication: United States